---
title: "AI Imaging Software, Definition | MedTech Terms"
description: "Software that analyzes medical images to triage, detect, or quantify disease. Plain-English Market Segments definition for MedTech teams, with examples and rela"
lang: en
json-ld: |
  {
    "@context": "https://schema.org",
    "@graph": [
      {
        "@type": "DefinedTerm",
        "@id": "https://medtechterms.com/terms/ai-imaging#term",
        "name": "AI Imaging Software",
        "description": "AI imaging software uses deep learning to detect findings (intracranial hemorrhage, large-vessel occlusion, pulmonary embolism, lung nodules), quantify disease burden (LVO, ejection fraction, breast density), or triage worklists.",
        "url": "https://medtechterms.com/terms/ai-imaging",
        "termCode": "ai-imaging",
        "inDefinedTermSet": {
          "@type": "DefinedTermSet",
          "name": "MedTech Terms",
          "url": "https://medtechterms.com/terms"
        }
      },
      {
        "@type": "Article",
        "@id": "https://medtechterms.com/terms/ai-imaging#article",
        "headline": "AI Imaging Software",
        "description": "Software that analyzes medical images to triage, detect, or quantify disease.",
        "url": "https://medtechterms.com/terms/ai-imaging",
        "mainEntityOfPage": {
          "@type": "WebPage",
          "@id": "https://medtechterms.com/terms/ai-imaging"
        },
        "about": {
          "@id": "https://medtechterms.com/terms/ai-imaging#term"
        },
        "articleSection": "Market Segments",
        "inLanguage": "en",
        "keywords": "AI Imaging Software, Market Segments, medical device, MedTech",
        "author": {
          "@type": "Person",
          "name": "Christian Espinosa",
          "jobTitle": "Founder, Blue Goat Cyber",
          "url": "https://bluegoatcyber.com"
        },
        "publisher": {
          "@type": "Organization",
          "name": "MedTech Terms",
          "url": "https://medtechterms.com"
        },
        "isPartOf": {
          "@type": "WebSite",
          "name": "MedTech Terms",
          "url": "https://medtechterms.com"
        },
        "datePublished": "2026-05-05",
        "dateModified": "2026-05-05",
        "citation": [
          {
            "@type": "CreativeWork",
            "name": "FDA AI/ML enabled devices list",
            "url": "https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-and-machine-learning-aiml-enabled-medical-devices",
            "publisher": {
              "@type": "Organization",
              "name": "FDA"
            }
          },
          {
            "@type": "CreativeWork",
            "name": "AdvaMed - Industry Reports",
            "url": "https://www.advamed.org/our-work/",
            "publisher": {
              "@type": "Organization",
              "name": "AdvaMed"
            }
          },
          {
            "@type": "CreativeWork",
            "name": "MedTech Europe - Facts & Figures",
            "url": "https://www.medtecheurope.org/datahub/",
            "publisher": {
              "@type": "Organization",
              "name": "MedTech Europe"
            }
          }
        ],
        "mentions": [
          {
            "@type": "DefinedTerm",
            "@id": "https://medtechterms.com/terms/samd#term",
            "name": "Software as a Medical Device",
            "alternateName": "SaMD",
            "url": "https://medtechterms.com/terms/samd"
          },
          {
            "@type": "DefinedTerm",
            "@id": "https://medtechterms.com/terms/medical-imaging#term",
            "name": "Medical Imaging",
            "url": "https://medtechterms.com/terms/medical-imaging"
          }
        ]
      },
      {
        "@type": "BreadcrumbList",
        "itemListElement": [
          {
            "@type": "ListItem",
            "position": 1,
            "name": "Home",
            "item": "https://medtechterms.com/"
          },
          {
            "@type": "ListItem",
            "position": 2,
            "name": "Terms",
            "item": "https://medtechterms.com/terms"
          },
          {
            "@type": "ListItem",
            "position": 3,
            "name": "Market Segments",
            "item": "https://medtechterms.com/terms?cat=Market%20Segments"
          },
          {
            "@type": "ListItem",
            "position": 4,
            "name": "AI Imaging Software",
            "item": "https://medtechterms.com/terms/ai-imaging"
          }
        ]
      },
      {
        "@type": "FAQPage",
        "@id": "https://medtechterms.com/terms/ai-imaging#faq",
        "mainEntity": [
          {
            "@type": "Question",
            "name": "How is AI imaging software classified by regulators?",
            "acceptedAnswer": {
              "@type": "Answer",
              "text": "The classification of AI imaging software depends on its intended use and the level of risk it poses to patients. This can range from lower risk classifications, requiring less stringent oversight, to higher risk classifications, demanding extensive clinical evidence and regulatory review. For example, the FDA's risk-based framework for SaMD is a key determinant."
            }
          },
          {
            "@type": "Question",
            "name": "What is the significance of a Predetermined Change Control Plan (PCCP) for AI imaging software?",
            "acceptedAnswer": {
              "@type": "Answer",
              "text": "A PCCP outlines the types of modifications an AI/ML-enabled SaMD can undergo without requiring a new 510(k) submission, provided the changes fall within the pre-specified parameters. This plan facilitates more agile updates while maintaining regulatory compliance. The FDA encourages the use of PCCPs for these adaptive systems."
            }
          },
          {
            "@type": "Question",
            "name": "What cybersecurity considerations apply to AI imaging software?",
            "acceptedAnswer": {
              "@type": "Answer",
              "text": "AI imaging software must adhere to cybersecurity principles to protect patient data and ensure device functionality. This includes implementing robust access controls, encryption, vulnerability management, and ensuring the integrity and authenticity of AI models and their outputs, as outlined in FDA cybersecurity guidance."
            }
          },
          {
            "@type": "Question",
            "name": "Is clinical validation required for AI imaging software?",
            "acceptedAnswer": {
              "@type": "Answer",
              "text": "Yes, clinical validation is crucial to demonstrate that the AI imaging software performs as intended in a clinical setting and provides accurate and reliable results. This involves rigorous testing with clinical data to support safety and effectiveness claims, aligning with requirements from bodies like the FDA and under the EU MDR."
            }
          }
        ]
      }
    ]
  }
---

[

MedTech Terms

The authoritative reference



](/)

Browse

Learn

[Latest](/latest)

About

1.  [Home](/)
2.  /
3.  [Terms](/terms)
4.  /
5.  [Market Segments](/terms?cat=Market%20Segments)
6.  /
7.  AI Imaging Software

[All terms](/terms)

Market Segments [AI / ML in Devices](/ecosystems/ai-ml)[Software Lifecycle](/ecosystems/software-lifecycle)[Strategic Landscape](/ecosystems/strategic-landscape)

# AI Imaging Software

Software that analyzes medical images to triage, detect, or quantify disease.

Reviewed by [Christian Espinosa, Founder, Blue Goat Cyber](/authors/christian-espinosa) Last reviewed May 5, 2026 

## Definition

AI imaging software uses deep learning to detect findings (intracranial hemorrhage, large-vessel occlusion, pulmonary embolism, lung nodules), quantify disease burden (LVO, ejection fraction, breast density), or triage worklists. 

What the regulation says

AI imaging software, as a type of Medical Device Software (MDSW), is subject to regulatory oversight by bodies like the FDA in the United States and under the  [EU Medical Device Regulation](/terms/mdr) ( [MDR](/terms/mdr-reporting)). Regulators classify these devices based on their risk to patients, influencing the conformity assessment routes and pre-market submission requirements. For instance, the FDA provides guidance on Artificial Intelligence/Machine Learning (AI/ML)-Based  [Software as a Medical Device](/terms/samd) (SaMD) to clarify expectations for these adaptive systems. 

## What this means in practice

Cleared as  [SaMD](/terms/samd); commercial success depends on hospital workflow integration, PACS connectivity, and dedicated reimbursement ( [NTAP](/terms/ntap), Category III  [CPT](/terms/cpt-codes)). Growing  [Predetermined Change Control Plan](/terms/ai-ml-pccp) (PCCP) adoption for model updates. 

## Examples

-   An AI imaging software cleared to detect intracranial hemorrhage on CT scans must demonstrate its accuracy and reliability through clinical validation studies, aligning with FDA guidance on SaMD.
-   A manufacturer implements a Predetermined Change Control Plan (PCCP) for its AI software that quantifies ejection fraction, allowing for pre-approved updates to the model's training data without requiring a new 510(k).
-   A hospital integrates an AI breast density quantification tool into its PACS system, ensuring compliance with HIPAA for patient data privacy and cybersecurity standards for software integration.

Common pitfalls

-   • A common pitfall is failing to validate the AI algorithm on diverse, representative datasets, leading to biased performance and inaccurate diagnoses in real-world clinical populations. 
-   • Another mistake is neglecting to establish robust post-market surveillance mechanisms to monitor the AI's performance drift and manage updates in a controlled manner. 
-   • Some manufacturers underestimate the regulatory burden associated with modifications to AI models, especially when the changes impact the safety or effectiveness of the device. 
-   • Assuming that a Predetermined Change Control Plan (PCCP) eliminates all regulatory submissions for AI model updates is incorrect; significant changes still require review. 
-   • Not adequately addressing cybersecurity risks, such as data privacy breaches or malicious attacks on the AI model, can lead to patient harm and regulatory non-compliance. 

## Frequently asked questions

How is AI imaging software classified by regulators? 

The classification of AI imaging software depends on its  [intended use](/terms/intended-use) and the level of risk it poses to patients. This can range from lower risk classifications, requiring less stringent oversight, to higher risk classifications, demanding extensive clinical evidence and regulatory review. For example, the FDA's risk-based framework for  [SaMD](/terms/samd) is a key determinant. 

What is the significance of a Predetermined Change Control Plan (PCCP) for AI imaging software? 

What cybersecurity considerations apply to AI imaging software? 

Is clinical validation required for AI imaging software? 

## Related terms

Grouped by theme 

### Editor's picks

· Hand-selected related concepts 

[

Market Segments

Medical Imaging

Devices that produce images of the body for diagnosis or guidance.





](/terms/medical-imaging)[

Software & AI

Software as a Medical Device(SaMD) 

Software intended for medical purposes that performs without being part of a hardware device.





](/terms/samd)

### More in Market Segments

· Same category 

[

Market Segments

Aesthetic & Energy-Based Devices

Lasers, RF, ultrasound, cryolipolysis, and IPL systems used for medical and cosmetic indications, body contouring, hair removal, skin tightening, vascular lesions.





](/terms/aesthetics-energy-devices)[

Market Segments

Cardiac Rhythm Management(CRM) 

Implantable and external devices that monitor and treat cardiac arrhythmias, pacemakers, ICDs, CRT devices, and insertable cardiac monitors.





](/terms/cardiac-rhythm-management)[

Market Segments

Cardiovascular Devices

Devices for diagnosing, monitoring, or treating cardiovascular disease.





](/terms/cardiovascular)[

Market Segments

Clinical Laboratory Improvement Amendments(CLIA) 

U.S. federal standards that govern clinical laboratory testing.





](/terms/clia)

Cited by

Where this term appears across MedTech Terms.

Ecosystems (3)

-   [AI / ML in Devices](/ecosystems/ai-ml)
-   [Software Lifecycle](/ecosystems/software-lifecycle)
-   [Strategic Landscape](/ecosystems/strategic-landscape)

## Primary references

3 sources 

Link health:  3 verified · last checked 2026-06-20 

FDA· 1 AdvaMed· 1 MedTech Europe· 1 

1.  [1 
    
    FDA AI/ML enabled devices list
    
    Verified 
    
    FDA · fda.gov 
    
    
    
    ](https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-and-machine-learning-aiml-enabled-medical-devices)
2.  [2 
    
    AdvaMed - Industry Reports
    
    Verified 
    
    AdvaMed · advamed.org 
    
    
    
    ](https://www.advamed.org/our-work/)
3.  [3 
    
    MedTech Europe - Facts & Figures
    
    Verified 
    
    MedTech Europe · medtecheurope.org 
    
    
    
    ](https://www.medtecheurope.org/datahub/)

Inline markers like \[1\]  jump to the matching reference above.

Sponsor note

### Building a connected device in this segment?

Blue Goat Cyber specializes in MedTech cybersecurity across imaging, cardiac, IVD, surgical, and other connected segments.

[Book a 30-minute discovery session](https://go.bluegoatcyber.com/meetings/blue-goat-cyber/discovery-session)

-   No obligation
-   Expert-led from minute one
-   NDA available on request

MedTech Terms is a community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com). Definitions are independent of any vendor.

On this term

Category

Market Segments

Sources

3

Updated

5/5/2026

[Compare with another term](/compare?a=ai-imaging)

Learn in 60 seconds

Card Lesson Quiz

Software that analyzes medical images to triage, detect, or quantify disease.

-   · Cleared as SaMD; commercial success depends on hospital workflow integration, PACS connectivity, and dedicated reimbursement (NTAP, Category III CPT). 
-   · Growing Predetermined Change Control Plan (PCCP) adoption for model updates. 

Remember this

Watch out: A common pitfall is failing to validate the AI algorithm on diverse, representative datasets, leading to biased performance and inaccurate diagnoses in real-world clinical populations.

Related terms

-   [Software as a Medical Device(SaMD) ](/terms/samd)
-   [Medical Imaging ](/terms/medical-imaging)

You may also need

Auto-suggested from Market Segments and shared keywords.

-   [Molecular Diagnostics ](/terms/molecular-diagnostics)
-   [Neuromodulation ](/terms/neuromodulation)
-   [Remote Patient Monitoring(RPM) ](/terms/remote-patient-monitoring)
-   [Women's Health Devices ](/terms/womens-health)
-   [Cardiovascular Devices ](/terms/cardiovascular)
-   [Digital Therapeutic(DTx) ](/terms/samd-dtx)

[All Market Segments terms](/terms?cat=Market%20Segments)

MedTech Terms 

An authoritative, plain-language reference for the regulatory, quality, cybersecurity, and software terms that shape modern medical devices.

Browse

-   [All terms](/terms)
-   [A–Z index](/a-z)
-   [Categories](/categories)
-   [Ecosystems](/ecosystems)
-   [Learning paths](/paths)
-   [Compare terms](/compare)
-   [Quiz](/quiz)

Resources

-   [FDA Medical Devices](https://www.fda.gov/medical-devices)
-   [EU MDR](https://eur-lex.europa.eu/eli/reg/2017/745/oj)
-   [IMDRF](https://www.imdrf.org/)
-   [Methodology](/methodology)
-   [Changelog](/changelog)
-   [Editor: Christian Espinosa](/authors/christian-espinosa)
-   [About this site](/about)

© 2026 MedTech Terms. Reference content for educational purposes - not regulatory advice. A community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com)